News & PR | alphatau

nicholas-cappello-Wb63zqJ5gnE-unsplash (1)_edited.jpg

Investors | Stock Information | SEC Filings | Events & Presentation | News & PR | Corporate Governance

New Alpha DaRT Research Collaboration on Immune Stimulation in the Treatment of Breast Cancer

Alpha Tau Medical

New Alpha DaRT Research Collaboration on Immune Stimulation in the Treatment of Breast Cancer

JERUSALEM, Jan 20, 2022 – Alpha Tau Medical Ltd. (“Alpha Tau”), the developer of the innovative alpha-radiation cancer therapy Alpha...

Results of First US Clinical Trial of Alpha DaRT™

Alpha Tau Medical

Results of First US Clinical Trial of Alpha DaRT™

Alpha Tau Announces Results of First US Clinical Trial of Alpha DaRT™ in Malignant Skin & Soft Tissue Cancers, Showing Complete Response...

Completion of Enrollment of Japanese Pivotal Clinical Trial in Recurrent Head & Neck Cancer

Alpha Tau Medical

Completion of Enrollment of Japanese Pivotal Clinical Trial in Recurrent Head & Neck Cancer

JERUSALEM, Dec. 31, 2021 -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha...

Enrollment of First Patient in Combination Trial of Alpha DaRT™ and Pembrolizumab (Keytruda®)

Alpha Tau Medical

Enrollment of First Patient in Combination Trial of Alpha DaRT™ and Pembrolizumab (Keytruda®)

JERUSALEM, Nov. 3, 2021 -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha...

Completion of Enrollment in 1st US Clinical Trial & Achievement of 1st Primary Objective

Alpha Tau Medical

Completion of Enrollment in 1st US Clinical Trial & Achievement of 1st Primary Objective

JERUSALEM, Oct. 25, 2021 -- Alpha Tau Medical Ltd. ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha...

Alpha Tau Receives FDA's Breakthrough Device Designation for the Treatment of Recurrent GBM

Alpha Tau Medical

Alpha Tau Receives FDA's Breakthrough Device Designation for the Treatment of Recurrent GBM

JERUSALEM, Oct. 8, 2021 -- Alpha Tau Medical, the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, is pleased to...

1

2 3 4 5